Actinium Pharmaceuticals, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Actinium Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Actinium Pharmaceuticals, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | J | 0.70 | 10,500 | 7,350 | 10,500 | |
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Option Exercise | J | 0.60 | 3,500 | 2,100 | 3,500 | |
| Mar 19 2018 | ATNM | Actinium Pharmaceu ... | Berger Mark Stanley | Chief Medical Offic ... | Buy | J | 0.50 | 14,000 | 7,000 | 19,000 | 5 K to 19 K (+280.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.70 | 39,375 | 27,563 | 39,375 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Option Exercise | J | 0.60 | 13,125 | 7,875 | 13,125 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | SETH SANDESH | Chairman & CEO | Buy | J | 0.50 | 52,500 | 26,250 | 128,333 | 75.8 K to 128.3 K (+69.23 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Option Exercise | J | 0.70 | 7,500 | 5,250 | 7,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Option Exercise | J | 0.60 | 2,500 | 1,500 | 2,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Ray Nitya G. | Executive VP | Buy | J | 0.50 | 10,000 | 5,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.70 | 5,250 | 3,675 | 5,250 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.60 | 1,750 | 1,050 | 1,750 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Buy | J | 0.50 | 7,000 | 3,500 | 9,500 | 2.5 K to 9.5 K (+280.00 %) |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | J | 0.70 | 7,500 | 5,250 | 7,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Option Exercise | J | 0.60 | 2,500 | 1,500 | 2,500 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | O'Loughlin Steve | Principal Financial ... | Buy | J | 0.50 | 10,000 | 5,000 | 13,500 | 3.5 K to 13.5 K (+285.71 %) |
| Mar 01 2018 | CTVN | Actinium Pharmaceu ... | Shetty Ajit | Director | Buy | P | 0.43 | 22,730 | 9,774 | 22,730 | 0 to 22.7 K |